FIRST CLICK HERE AND READ OUR OVERVIEW
According to research in Cancer Res (2005) lung cancer cells grow in response to oestrogen and researchers used gefitnib to block the pathway; with fulvestrant to block the growth factors. This resulted in 59 per cent of the sample having their tumours decrease.